|
1
|
Dy GW, Gore JL, Forouzanfar MH, Naghavi M
and Fitzmaurice C: Global burden of urologic cancers, 1990–2013.
Eur Urol. 71:437–446. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arnold M, Soerjomataram I, Ferlay J and
Forman D: Global incidence of oesophageal cancer by histological
subtype in 2012. Gut. 64:381–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alsop BR and Sharma P: Esophageal cancer.
Gastroenterol Clin North Am. 45:399–412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rice TW, Ishwaran H, Blackstone EH,
Hofstetter WL, Kelsen DP and Apperson-Hansen C; Worldwide
Esophageal Cancer Collaboration Investigators, : Recommendations
for clinical staging (cTNM) of cancer of the esophagus and
esophagogastric junction for the 8th edition AJCC/UICC staging
manuals. Dis Esophagus. 29:913–919. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rice TW, Gress DM, Patil DT, Hofstetter
WL, Kelsen DP and Blackstone EH: Cancer of the esophagus and
esophagogastric junction-major changes in the American joint
committee on cancer eighth edition cancer staging manual. CA Cancer
J Clin. 67:304–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lan T, Lu Y, Xiao Z, Xu H, He J, Hu Z and
Mao W: A six-microRNA signature can better predict overall survival
of patients with esophagus adenocarcinoma. PeerJ. 7:e73532019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan LY, Qin X, Li L, Zhou J, Zhou M, Li
X, Xu Y, Wang XJ and Xing H: The transcriptome profiles and
methylation status revealed the potential cancer-related lncRNAs in
patients with cervical cancer. J Cell Physiol. 234:9756–9763. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang YZ, Liu YR, Xu XE, Jin X, Hu X, Yu
KD and Shao ZM: Transcriptome Analysis of triple-negative breast
cancer reveals an integrated mRNA-lncRNA signature with predictive
and prognostic value. Cancer Res. 76:2105–2114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi YM, Li YY, Lin JY, Zheng L, Zhu YM and
Huang J: The discovery of a novel eight-mRNA-lncRNA signature
predicting survival of hepatocellular carcinoma patients. J Cell
Biochem. Nov. 28–2018.(Epub ahead of print).
|
|
12
|
Cancer Genome Atlas Research Network;
Analysis Working Group: Asan University; BC Cancer Agency; Brigham
and Women's Hospital; Broad Institute; Brown University; Case
Western Reserve University; Dana-Farber Cancer Institute; Duke
University et al, . Integrated genomic characterization of
oesophageal carcinoma. Nature. 541:169–175. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gu J, Zhang X, Miao R, Ma X, Xiang X, Fu
Y, Liu C, Niu W and Qu K: A three-long non-coding
RNA-expression-based risk score system can better predict both
overall and recurrence-free survival in patients with small
hepatocellular carcinoma. Aging (Albany NY). 10:1627–1639. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu JH, Zuo ZX, Wang W, Zhao Q, Qiu MZ, Luo
HY, Chen ZH, Mo HY, Wang F, Yang DD, et al: A two-microRNA-based
signature predicts first-line chemotherapy outcomes in advanced
colorectal cancer patients. Cell Death Discov. 4:1162018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao J, Kwan PW and Shi D: Sparse kernel
learning with LASSO and Bayesian inference algorithm. Neural Netw.
23:257–264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Allison KH and Sledge GW: Heterogeneity
and cancer. Oncology (Williston Park). 28:772–778. 2014.PubMed/NCBI
|
|
17
|
Peters CJ, Rees JR, Hardwick RH, Hardwick
JS, Vowler SL, Ong CA, Zhang C, Save V, O'Donovan M, Rassl D, et
al: A 4-gene signature predicts survival of patients with resected
adenocarcinoma of the esophagus, junction, and gastric cardia.
Gastroenterology. 139:1995–2004 e15. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meng J, Zhang J, Xiu Y, Jin Y, Xiang J,
Nie Y, Fu S and Zhao K: Prognostic value of an immunohistochemical
signature in patients with esophageal squamous cell carcinoma
undergoing radical esophagectomy. Mol Oncol. 12:196–207. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Chen Z, Tian L, Zhou C, He MY, Gao
Y, Wang S, Zhou F, Shi S, Feng X, et al: LncRNA profile study
reveals a three-lncRNA signature associated with the survival of
patients with oesophageal squamous cell carcinoma. Gut.
63:1700–1710. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan Q and Liu B: Identification of a
RNA-Seq based 8-long non-coding RNA signature predicting survival
in esophageal cancer. Med Sci Monit. 22:5163–5172. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang SC: PCNA: A silent housekeeper or a
potential therapeutic target? Trends Pharmacol Sci. 35:178–186.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou H, Huang T, Xiong Y, Peng L, Wang R
and Zhang GJ: The prognostic value of proliferating cell nuclear
antigen expression in colorectal cancer: A meta-analysis. Medicine
(Baltimore). 97:e137522018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu L, Li HL, Li WF, Chen JM, Yang JT, Gu
JJ and Xin L: Clinical significance of expression of proliferating
cell nuclear antigen and E-cadherin in gastric carcinoma. World J
Gastroenterol. 23:3721–3729. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stenner M, Demgensky A, Molls C, Hardt A,
Luers JC, Grosheva M, Huebbers CU and Klussmann JP: Prognostic
value of proliferating cell nuclear antigen in parotid gland
cancer. Eur Arch Otorhinolaryngol. 269:1225–1232. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kinugasa S, Tachibana M, Hishikawa Y, Abe
S, Yoshimura H, Monden N, Dhar DK and Nagasue N: Prognostic
significance of proliferating cell nuclear antigen (PCNA) in
squamous cell carcinoma of the esophagus. Jpn J Clin Oncol.
26:405–410. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kimos MC, Wang S, Borkowski A, Yang GY,
Yang CS, Perry K, Olaru A, Deacu E, Sterian A, Cottrell J, et al:
Esophagin and proliferating cell nuclear antigen (PCNA) are
biomarkers of human esophageal neoplastic progression. Int J
Cancer. 111:415–417. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Al-Ghamdi S, Albasri A, Cachat J, Ibrahem
S, Muhammad BA, Jackson D, Nateri AS, Kindle KB and Ilyas M: Cten
is targeted by kras signalling to regulate cell motility in the
colon and pancreas. PLoS One. 6:e209192011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chan LK, Chiu YT, Sze KM and Ng IO:
Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes
cell proliferation and migration in hepatocellular carcinoma.
Oncotarget. 6:20964–20976. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Al-Ghamdi S, Cachat J, Albasri A, Ahmed M,
Jackson D, Zaitoun A, Guppy N, Otto WR, Alison MR, Kindle KB and
Ilyas M: C-terminal tensin-like gene functions as an oncogene and
promotes cell motility in pancreatic cancer. Pancreas. 42:135–140.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liao YC, Chen NT, Shih YP, Dong Y and Lo
SH: Up-regulation of C-terminal tensin-like molecule promotes the
tumorigenicity of colon cancer through beta-catenin. Cancer Res.
69:4563–4566. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martuszewska D, Ljungberg B, Johansson M,
Landberg G, Oslakovic C, Dahlbäck B and Hafizi S: Tensin3 is a
negative regulator of cell migration and all four tensin family
members are downregulated in human kidney cancer. PLoS One.
4:e43502009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu WM and Liao YC: Downregulation of
C-terminal tensin-like protein (CTEN) suppresses prostate cell
proliferation and contributes to acinar morphogenesis. Int J Mol
Sci. 19:E31902018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nie F, Yu X, Huang M, Wang Y, Xie M, Ma H,
Wang Z, De W and Sun M: Long noncoding RNA ZFAS1 promotes gastric
cancer cells proliferation by epigenetically repressing KLF2 and
NKD2 expression. Oncotarget. 8:38227–38238. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang W and Xing C: Upregulation of long
noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion
and metastasis in colorectal cancer. Pathol Res Pract. 212:690–695.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Deng X, Chen H, Shen B, Peng C, et al: Amplification of long
noncoding RNA ZFAS1 promotes metastasis in hepatocellular
carcinoma. Cancer Res. 75:3181–3191. 2015. View Article : Google Scholar : PubMed/NCBI
|
